Dr. Mohammad Owais | Nanovaccine | Best Researcher Award

Aligarh Muslim University, Aligarh | India

Author Profile

Scopus

Orcid ID

Google Scholar

🧬 PROFESSOR MOHAMMAD OWAIS: A PIONEER IN BIOTECHNOLOGY AND NANOMEDICINE

🎓EARLY ACADEMIC PURSUITS

Dr. Mohammad Owais was born on July 1, 1962. He began his academic journey with a Bachelor's degree in Pharmacy from Delhi University in 1987, followed by an M.Sc. in Biotechnology from Jawaharlal Nehru University (JNU), New Delhi, in 1989. He later earned his Ph.D. in Biotechnology from the prestigious Panjab University, Chandigarh, in 1996. His solid foundation in pharmaceutical and biotechnological sciences laid the groundwork for a career marked by innovation and excellence.

👨‍🔬 PROFESSIONAL ENDEAVORS

Currently a Professor at the Interdisciplinary Biotechnology Unit, Aligarh Muslim University (AMU), Dr. Owais has been a torchbearer in the field of biotechnology. His academic contributions are matched by his dedication to nurturing the next generation of scientists through graduate and doctoral teaching.

In parallel, he has played a critical role in institutional leadership, technological innovation, and translational research. He has successfully led several projects involving liposome and nano-based drug delivery systems, establishing AMU as a notable center for biotechnology research in India.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON NANOVACCINE

Dr. Owais is a recognized expert in drug/antigen targeting, with significant contributions to nanovaccine development. His research focus includes:

  • Nanoparticles for antigen/DNA vaccine delivery against infectious diseases

  • Targeted delivery of therapeutic agents (e.g., siRNA, anti-cancer drugs)

  • Nano-carriers for diagnostics, taste/odor masking, and treatment of conditions like hyperbilirubinemia

  • Innovation in liposomes, dendrimers, virosomes, and solid-core nanoparticles

He has successfully translated this research into practical therapeutics, evidenced by his patents and technology transfers.

📚 ACADEMIC CITES AND INTELLECTUAL CONTRIBUTIONS

Books Authored (Selected):

  1. Modern Phytomedicine (Wiley VCH, 2006)

  2. Trypanothione Reductase (VDM Verlag, 2009)

  3. Combating Fungal Infections (Springer-Verlag, 2010)

  4. Antimicrobial Properties of Clove Oil (2011)

Patents (Selected):

  • Nano-particle based polyene antifungal formulations

  • Bispecific antibodies for foodborne pathogen detection (US Patent)

  • Herbal liposomal formulations

  • siRNA-loaded subtilosome for hepatocellular carcinoma

Top-Ranked Articles:

  • Vaccine research on Plasmodium yoelii nigeriensis

  • Drug encapsulation for Leishmania donovani

  • Research highlighted by journals like FEMS Immunology, Molecular Medicine, and Biochimica et Biophysica Acta

🏆 IMPACT AND INFLUENCE

Dr. Owais's work has been internationally recognized:

  • National Bioscience Award – DBT, Govt. of India (2007)

  • TATA Innovation Award (2013)

  • Rashtriya Gaurav Award, VIFRA Distinguished Scientist Award, and Indus Research Excellence Award

  • Fogarty International Fellowship from NIH, USA

  • Research cited among Top 25 Science Direct articles

He has mentored countless young researchers and is a member of editorial boards of major journals such as Frontiers in Immunology, Molecules (MDPI), Nanotechnology Nanomaterials, and BioMed Research International.

🌍 NATIONAL & INTERNATIONAL COLLABORATIONS

Dr. Owais has contributed to several technology transfers to pharmaceutical companies like Cadila Pharmaceuticals and Gennova Biopharmaceuticals, showcasing his translational strength in bridging research and industry.

He also served on the International Advisory Board of the Liposome Research Days held in Canada, underlining his global presence in the field.

👨‍🏫 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Mohammad Owais has already left an indelible mark on the Indian scientific landscape. His legacy is built on:

  • Pioneering nano-biotechnology platforms for disease prevention and therapy

  • Training the next generation of Indian scientists

  • Leading clinical trials for herbal formulations, including trials for COVID-19 treatments

Looking ahead, Dr. Owais is well-positioned to further enhance the interdisciplinary interface between biotechnology and nanomedicine, contributing to affordable healthcare solutions and scientific excellence.

📝 SUMMARY AT A GLANCE

  • Name: Dr. Mohammad Owais

  • DOB: July 1, 1962

  • Designation: Professor, Interdisciplinary Biotechnology Unit, AMU

  • Specialization: Drug/antigen targeting, Nano-vaccine development

  • Total Books Authored: 4

  • Patents Filed: 6 (including US & Indian patents)

  • Major Awards: National Bioscience Award, TATA Innovation Award, NIH Fellowship

  • Editorial Boards: Member of 15+ reputed journals

  • Notable Contributions: Technology transfer to industry, cover-page featured articles, national/international recognition

📑NOTABLE PUBLICATIONS

"Targeting Azole-Resistant Candida albicans: Tetrapeptide Tuftsin-Modified Liposomal Vaccine Induces Superior Immune Protection" 

  • Authors: Masood A. Khan; Arif Khan; Abdullah M. Alnuqaydan; Aqel Albutti; Basmah F. Alharbi; Mohammad Owais
  • Journal: Vaccines
  • Year: 2025

"Crosstalk between SARS-CoV-2 Infection and Neurological Disorders: A Review" 

  • Authors: Asim Azhar; Mohammad Akram Wali; Qudsia Rashid; Wajihul Hasan Khan; Khaled Al-hosaini; Mohammad Owais; Mohammad Amjad Kamal
  • Journal: CNS & Neurological Disorders - Drug Targets
  • Year: 2023

"Multifaceted Pharmacological Potentials of Curcumin, Genistein, and Tanshinone IIA through Proteomic Approaches: An In-Depth Review" 

  • Authors: Farheen Badrealam Khan; Parul Singh; Yahya F. Jamous; Syed Azmal Ali; Abdullah; Shahab Uddin; Qamar Zia; Manoj Kumar Jena; Mohsina Khan; Mohammad Owais et al.
  • Journal: Cancers
  • Year: 2022

"Rumex nervosus mediated green synthesis of silver nanoparticles and evaluation of its in vitro antibacterial, and cytotoxic activity" 

  • Authors: Ansam Wadia Alshameri; Mohammad Owais; Ishrat Altaf; Saba Farheen
  • Journal: OpenNano
  • Year: 2022

"An insight on safety, efficacy, and molecular docking study reports of N-acetylcysteine and its compound formulations" 

  • Authors: Farheen Badrealam Khan; Parul Singh; Yahya F. Jamous; Syed Azmal Ali; Abdullah; Shahab Uddin; Qamar Zia; Manoj Kumar Jena; Mohsina Khan; Mohammad Owais et al.
  • Journal: Journal of Basic and Clinical Physiology and Pharmacology
  • Year: 2021
Mohammad Owais | Nanovaccine | Best Researcher Award